End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48 TWD | +1.05% | +4.12% | -26.27% |
03-14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-06 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
Sales 2022 | 22.4 729.38 1.79K | Sales 2023 | 61.41 2K 4.91K | Capitalization | 8.71B 284B 697B |
---|---|---|---|---|---|
Net income 2022 | -1.64B -53.42B -131B | Net income 2023 | -2.14B -69.57B -171B | EV / Sales 2022 | 599,427,887 x |
Net Debt 2022 | 1.05B 34.28B 84.24B | Net Debt 2023 | 1.35B 43.98B 108B | EV / Sales 2023 | 163,906,538 x |
P/E ratio 2022 |
-7.54
x | P/E ratio 2023 |
-3.93
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.81% |
1 day | +1.05% | ||
1 week | +4.12% | ||
Current month | -1.44% | ||
1 month | -0.21% | ||
3 months | -26.38% | ||
6 months | -35.57% | ||
Current year | -26.27% |
Managers | Title | Age | Since |
---|---|---|---|
Kuan Hao Lin
DFI | Director of Finance/CFO | - | 17/02/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
ALLEN Chao
FOU | Founder | 78 | 07/05/13 |
Ta Meng Tseng
BRD | Director/Board Member | 66 | 05/10/13 |
Chih Chuan Chen
BRD | Director/Board Member | - | 05/10/13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 48 | +1.05% | 392,713 |
25/04/24 | 47.5 | +0.64% | 176,187 |
24/04/24 | 47.2 | -1.56% | 339,403 |
23/04/24 | 47.95 | +5.73% | 880,776 |
22/04/24 | 45.35 | -1.63% | 888,348 |
End-of-day quote Taiwan S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-26.27% | 241M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 6541 Stock